| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $383.5M | +38.4% |
| Cost of Revenue | $44.5M | +79.8% |
| Gross Profit | $339.0M | +34.4% |
| R&D Expense | $74.2M | +45.5% |
| SG&A Expense | $292.8M | +53.8% |
| Operating Income | -$28.1M | -359.1% |
| Interest Expense | $294K | -0.3% |
| Pre-tax Income | -$26.2M | -345.1% |
| Income Tax | $3.1M | +264.7% |
| Net Income | -$29.3M | -397.4% |
| EPS (Basic) | -$0.55 | -375.0% |
| EPS (Diluted) | -$0.55 | -405.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $60.2M | -35.1% |
| Short-term Investments | $266.2M | +219.4% |
| Accounts Receivable | $58.6M | +38.4% |
| Inventory | $32.6M | +54.8% |
| Current Assets | $422.9M | +72.5% |
| Total Assets | $504.2M | +61.8% |
| Current Liabilities | $56.2M | +32.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.0M | -154.8% |
| Capital Expenditures | $10.0M | -27.1% |
| Investing Cash Flow | -$195.2M | -282.6% |
| Financing Cash Flow | $177.1M | +4249.1% |
| Free Cash Flow | -$23.9M | -302.0% |
| Total Liabilities |
| $87.2M |
| +20.5% |
| Stockholders' Equity | $417.0M | +74.3% |